✦ LIBER ✦

Identification of a Drosophila brain-gut peptide related to the neuropeptide Y family

✍ Scribed by Mark R Brown; Joe W Crim; Ryan C Arata; Haini N Cai; Cao Chun; Ping Shen

Book ID: 117409415
Publisher: Elsevier Science
Year: 1999
Tongue: English
Weight: 355 KB
Volume: 20
Category: Article
ISSN: 0196-9781
DOI: 10.1016/s0196-9781(99)00097-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

New vertebrate brain–gut peptide related

New vertebrate brain–gut peptide related to a molluscan neuropeptide and an opioid peptide

✍ Dockray, Graham J.; Vaillant, Camille; Williams, R. G. 📂 Article 📅 1981 🏛 Nature Publishing Group 🌐 English ⚖ 326 KB

Evaluation of the behavioral effects of

Evaluation of the behavioral effects of peptides related to neuropeptide Y

✍ P. Broqua; J.G. Wettstein; B. Gauthier-Martin; J.L. Junien 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 129 KB

Neuropeptide Y — A newly discovered pept

Neuropeptide Y — A newly discovered peptide of the pancreatic polypeptide family is present in the rat brain

✍ Allen, YS; Crow, TJ; Bloom, SR; Polak, JM 📂 Article 📅 1982 🏛 Elsevier Science 🌐 English ⚖ 54 KB

Identification of the novel bioactive pe

Identification of the novel bioactive peptides dRYamide-1 and dRYamide-2, ligands for a neuropeptide Y-like receptor in Drosophila

✍ Takanori Ida; Tomoko Takahashi; Hatsumi Tominaga; Takahiro Sato; Kazuhiko Kume; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 739 KB

Purification of a neuropeptide Y-related

Purification of a neuropeptide Y-related peptide from the brain of the sea lamprey and its effect on steroidogenesis

✍ J. Michael Conlon; Ambikaipakan Balasubramaniam; Stacia A. Sower 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 606 KB

The identification of a series of novel,

The identification of a series of novel, soluble non-peptidic neuropeptide Y Y2 receptor antagonists

✍ Gillian E. Lunniss; Ashley A. Barnes; Nick Barton; Matteo Biagetti; Federica Bia 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 678 KB

The identification and subsequent optimisation of a selective non-peptidic NPY Y2 antagonist series is described. This led to the development of amine 2, a selective, soluble NPY Y2 receptor antagonist with enhanced CNS exposure.